Skip to main content
. 2020 May 31;37(6):114. doi: 10.1007/s11095-020-02816-w

Fig. 7.

Fig. 7

Thermal stability and forced degradation of ABP 710 and infliximab RP. Fragmentation (LMW + MMW) results by rCE-SDS are shown for (a) accelerated thermal stability at 25°C; (b) stressed thermal stability at 40°C; and (c) reconstituted drug product at 40°C. Acidic charge variants results by CEX-HPLC are shown for (d) accelerated thermal stability at 25°C; (e) stressed thermal stability at 40°C; and (f) reconstituted drug product at 40°C.